JP2023532170A5 - - Google Patents

Info

Publication number
JP2023532170A5
JP2023532170A5 JP2022563209A JP2022563209A JP2023532170A5 JP 2023532170 A5 JP2023532170 A5 JP 2023532170A5 JP 2022563209 A JP2022563209 A JP 2022563209A JP 2022563209 A JP2022563209 A JP 2022563209A JP 2023532170 A5 JP2023532170 A5 JP 2023532170A5
Authority
JP
Japan
Prior art keywords
composition according
infection
coronavirus
rsv
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/050333 external-priority patent/WO2021207790A1/en
Publication of JP2023532170A publication Critical patent/JP2023532170A/ja
Publication of JP2023532170A5 publication Critical patent/JP2023532170A5/ja
Pending legal-status Critical Current

Links

JP2022563209A 2020-04-15 2021-04-14 コロナウイルス及び／又は呼吸器合胞体ウイルス感染症の予防の方法 Pending JP2023532170A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2020901194 2020-04-15
AU2020901194A AU2020901194A0 (en) 2020-04-15 Method of prophylaxis of coronavirus infection
AU2020902993A AU2020902993A0 (en) 2020-08-21 Method of prophylaxis of coronavirus infection
AU2020902993 2020-08-21
AU2020904246A AU2020904246A0 (en) 2020-11-17 Method of prophylaxis of respiratory syncytial virus infection
AU2020904246 2020-11-17
PCT/AU2021/050333 WO2021207790A1 (en) 2020-04-15 2021-04-14 Method of prophylaxis of coronavirus and/or respiratory syncytial virus infection

Publications (2)

Publication Number Publication Date
JP2023532170A JP2023532170A (ja) 2023-07-27
JP2023532170A5 true JP2023532170A5 (https=) 2024-04-22

Family

ID=78083455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563209A Pending JP2023532170A (ja) 2020-04-15 2021-04-14 コロナウイルス及び／又は呼吸器合胞体ウイルス感染症の予防の方法

Country Status (8)

Country Link
US (1) US20230330134A1 (https=)
EP (1) EP3930730A4 (https=)
JP (1) JP2023532170A (https=)
CN (1) CN116056714A (https=)
AU (2) AU2021204697B1 (https=)
GB (3) GB2599799B (https=)
SG (1) SG11202112332VA (https=)
WO (1) WO2021207790A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4282420A4 (en) * 2021-01-20 2024-11-27 National University Corporation Hokkaido University ANTIVIRAL AGENT
CN114107223B (zh) * 2021-11-25 2024-03-26 湖北省疾病预防控制中心（湖北省预防医学科学院） 利用TPCK胰酶提高SARS-CoV-2病毒细胞培养滴度的方法
CN113967211B (zh) * 2021-12-15 2023-03-28 山东达因海洋生物制药股份有限公司 盐酸石蒜碱硫酯在制备抗冠状病毒药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
AUPO104396A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
PL1937284T3 (pl) * 2005-10-18 2016-05-31 Starpharma Pty Ltd System podawania kompozycji bakteriobójczego dendymeru
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
KR20180126621A (ko) * 2011-05-16 2018-11-27 스타파마 피티와이 리미티드 세균성 질염의 치료 또는 예방 방법
JP6419701B2 (ja) * 2012-09-13 2018-11-07 スターファーマ・ピーティーワイ・リミテッド 眼の感染症の治療または予防方法
BR112018072741A2 (pt) * 2016-05-05 2019-02-19 Starpharma Pty Ltd método para a profilaxia de infecção pelo vírus da zika
CN115803023A (zh) * 2020-05-08 2023-03-14 施万生物制药研发Ip有限责任公司 发用奈珠西替尼治疗感染冠状病毒的患者的方法
AU2021271330A1 (en) * 2020-05-14 2022-12-15 Palani Llc A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections

Similar Documents

Publication Publication Date Title
JP2023532170A5 (https=)
CN111228275B (zh) 一种化合物在制备治疗病毒性肺炎药物中的应用
JP2004505046A5 (https=)
CN115697382A (zh) 具有抗病毒作用的口服使用的乳铁蛋白
JP2024170583A5 (https=)
JP2023520323A5 (https=)
AU2024278473A1 (en) Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis
CN111249454A (zh) 灭活卡介苗在预防或治疗新冠病毒相关病况中的用途
GB2599799A (en) Method of prophylaxis of Coronavirus and/or respiratory syncytial virus infection
EP2606898A1 (en) Composition comprising ligustroflavone, rhoifolin and hyperin, and use thereof in the preparation of a medicament
CN101906122B (zh) 野漆树苷的提取方法及其制备药物用途
CN113855685A (zh) 糖皮质激素在制备治疗和/或预防呼吸道病毒感染的药物中的用途
CN103720650A (zh) 一种具有抗流感病毒作用的黄芩苷注射剂
JP2010528053A (ja) インフルエンザ感染症を治療するための物質および方法
CN112805027A (zh) 一种抗新冠病毒感染的药物、食物与应用
CN102633850A (zh) 野漆树苷的提取方法及其制备药物用途
CN105496992A (zh) 氨溴索沙丁胺醇脂质固体分散体
CN104721221B (zh) 琼枝麒麟菜多糖用于制备抗呼吸道病毒药物中的用途
Singh Potential role of Curcumin against viral infections with a view on structure and pathogenesis of COVID-19
CN105434631A (zh) 花椒精油在制备用于预防和/或治疗病毒性流感的药物或保健品中的应用
US11780871B1 (en) COVID-19 treatment and methods
CN105456240B (zh) 氨溴索沙丁胺醇气雾剂
CN121712513A (zh) 包含黄原胶或褐藻多糖的用于抗流感病毒的组合物
CN117653637A (zh) 恩替卡韦的新用途
CN111346094A (zh) 一种用于治疗支气管炎和支气管哮喘的组合物及其制备方法